From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.

tafolecimab   Click here for help

GtoPdb Ligand ID: 12517

Synonyms: IBI-306 | IBI306 | Sintbilo®
Approved drug
tafolecimab is an approved drug (China (2023))
Compound class: Antibody
Comment: Tafolecimab (IBI-306; Innovent Biologics) is a fully human proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody. Based on protein sequence alignments, we suspect that tafolecimab is one of the monoclonals that are claimed in Innovent Biologics' patent US11485795: Anti-PCSK9 antibody and use thereof [4].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
proprotein convertase subtilisin/kexin type 9 Hs Antibody Binding - - - 4
⤷ [4]